Based on the RE-LY study, a 150-mg dose of dabigatran as compared with ... Based on the AVEROSS trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention ...

Further trials comparing aspirin with newer anticoagulants (dabigatran ... Based on the RE-LY study, a 150-mg dose of dabigatran as compared with warfarin was shown to reduce the rate of stroke ...

Previous trials have used a wide range of doses, from 60-150 mg daily. In terms of prophylaxis for people at high risk of ...